Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Gains from Investment Securities (2019 - 2025)

AdaptHealth has reported Gains from Investment Securities over the past 7 years, most recently at $12.1 million for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $12.1 million for Q4 2025, up 408.62% from a year ago — trailing twelve months through Dec 2025 was $13.4 million (up 223.49% YoY), and the annual figure for FY2025 was $24.3 million, up 1241.12%.
  • Gains from Investment Securities for Q4 2025 was $12.1 million at AdaptHealth, up from $1.3 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for AHCO hit a ceiling of $12.1 million in Q4 2025 and a floor of -$39.7 million in Q4 2023.
  • Median Gains from Investment Securities over the past 5 years was $31000.0 (2021), compared with a mean of -$5.7 million.
  • Biggest five-year swings in Gains from Investment Securities: tumbled 5626.91% in 2021 and later skyrocketed 2142.84% in 2022.
  • AdaptHealth's Gains from Investment Securities stood at -$27.4 million in 2021, then soared by 105.44% to $1.5 million in 2022, then plummeted by 2761.42% to -$39.7 million in 2023, then skyrocketed by 90.13% to -$3.9 million in 2024, then soared by 408.62% to $12.1 million in 2025.
  • The last three reported values for Gains from Investment Securities were $12.1 million (Q4 2025), $1.3 million (Q1 2025), and -$3.9 million (Q4 2024) per Business Quant data.